An interventional study of Absorbable running intradermal suture and Non-absorbable interrupted transdermal suture in Brain Tumor Adult, Brain Tumor Benign and Meningioma, sponsored by Medical University of Warsaw. Recruiting at 2 sites in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Medical University of Warsaw · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Brain Neoplasms with a site in Poland — 4 open to participants now, 8 under way, 2 of them phase 3. Brain Neoplasms · Poland.
Among the 24 studies in Brain Neoplasms with a site in Poland, this one is the 6th largest by planned enrollment of the 21 interventional ones that give a count, is one of 2 that started in 2026, is one of 5 with no phase, and was the 23rd registered.
2,447 studies on the registry are indexed under Brain Neoplasms; 546 are open to participants now.
Browse Brain Neoplasms studies →4 of the 24 studies in Brain Neoplasms with a site in Poland are open now. Recruiting first, the newest first:
Medical University of Warsaw · Sites in Poland
Ages 18+
Copernicus Memorial Hospital · Sites in Poland
Ages 18–70
The Greater Poland Cancer Centre · Sites in Poland
Ages 18–70
A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →
Of the 429 Brain Neoplasms studies recruiting now, 289 (67%) set no upper age limit and 83 (19%) stop at 75 or younger; 80 take children under 18; 37 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 7 · Phase 3 10
First in 1999; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 382 is above the median of 40 across 1,838 interventional studies indexed under Brain Neoplasms.
Median enrollment 245 across the 21 interventional studies, 125 across the 3 observational. Of the 13 that completed or were terminated, 8 (62%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 24 have an industry lead sponsor. The 10 most frequent:
Medical University of Warsaw is the lead sponsor of 327 studies on the registry; 88 are open to participants now.
Medical University of Warsaw has 2 studies filed under Brain Neoplasms — fewer than ten, so there is no comparison to draw.
1 of the studies in Brain Neoplasms with a site in Poland that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02066220Phase 3Universitätsklinikum Hamburg-EppendorfInternational Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Brain Neoplasms with a site in Poland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare two commonly used methods of closing the skin after surgery for an intracranial tumor. Skin closure is one of the most important steps in neurosurgical procedures, as it has a major influence on how well the wound heals. In patients with brain tumors, proper wound healing is especially important because it may affect how soon additional treatments, such as radiotherapy or chemotherapy, can be started.
There are different ways to close the skin after surgery, including running sutures and interrupted sutures. Both methods are widely used and considered safe. However, in oncological neurosurgery, there is limited scientific evidence comparing their effects, and the choice of technique is often based on the surgeon's personal experience. In this study, investigators will compare skin closure using running absorbable sutures with interrupted non-absorbable sutures. Investigators will evaluate how well, depending on used suturing methods, the wound heals and how often wound-related complications occur, such as infection, separation of the wound edges, or leakage of cerebrospinal fluid. Investigators believe that the results of this study will help improve wound care in patients undergoing neurosurgical treatment for brain tumors and, as a result, may contribute to better recovery and overall quality of life.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Absorbable running intradermal suture
Other: Non-absorbable interrupted transdermal suture
Absorbable sutures used to perform continuous/running intradermal skin closure.
Non-absorbable sutures used to perform interrupted transdermal skin closure.
Occurrence of surgical wound healing complication.
The primary outcome of this trial is the occurrence of surgical wound healing complication including wound dehiscence (defined as separation of wound edges longer than 1 cm), surgical site infection or external cerebrospinal fluid leak.
Time frame: From enrollment to the final wound assessment time point - 90 days postoperatively.
Aesthetic quality of wound healing - observer perspective.
Aesthetic quality of postoperative wound/scar, evaluated using the Patient and Observer Scar Assessment Scale (from 9 to 45 points for Observer score) where higher scores indicate worse healing outcomes.
Time frame: From enrollment to the final wound assessment time point - 90 days postoperatively.
Aesthetic quality of wound healing - patient perspective.
Aesthetic quality of postoperative wound/scar, evaluated using the Patient and Observer Scar Assessment Scale (from 17 to 85 points for Patient score) where higher scores indicate worse healing outcomes.
Time frame: From enrollment to the final wound assessment time point - 90 days postoperatively.
Aesthetic quality of wound healing - observer perspective.
Aesthetic quality of postoperative wound/scar using Visual Analogue Scale (from 1 to 10 pints) in observer's perspective where higher score indicates better wound healing outcomes.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Aesthetic quality of wound healing - patient perspective.
Aesthetic quality of postoperative wound/scar using Visual Analogue Scale (from 1 to 10 points) in patient's perspective where higher score indicates better wound healing outcomes.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Pain or discomfort related to sutures removal
Pain/discomfort during sutures removal assessed using Visual Analogue Scale (from 1 to 10 points) among subjects receiving non-absorbable sutures where higher score stands for the worst pain ever felt.
Time frame: At the time of non-absorbable sutures removal - typically 7-10 days postoperatively.
Incidence and nature of additional interventions - invasive interventions - sutures.
Incidence and nature of additional invasive interventions due to suboptimal wound/scar formation: \- placement of additional sutures within the wound. Amount of sutures added and timing of sutures placement after primary surgical intervention.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Incidence and nature of additional interventions - invasive interventions - lumbar drainage.
Incidence and nature of additional invasive interventions due to suboptimal wound/scar formation: \- lumbar drainage placement Timing of lumbar drainage placement after primary surgical intervention and it's duration.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Incidence and nature of additional interventions - invasive interventions - secondary surgical intervention.
Incidence and nature of additional invasive interventions due to suboptimal wound/scar formation: \- secondary surgical intervention (re-operation). Timing of secondary surgical intervention after primary surgical intervention.
Time frame: From enrollment to the final woun assessment timepoint - 90 days postoperatively.
Incidence and nature of additional interventions - conservative management
Incidence and nature of additional conservative management interventions due to suboptimal wound/scar formation, such as: antibiotic therapy and/or pharmacologic therapy - type of drugs used for management and it's duration.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively
Incidence of external cerebrospinal fluid leak
Incidence of cerebrospinal fluid leakage through the wound margins.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Surgical site infections - deep infections.
Incidence of deep surgical site infections, based on clinical and/or radiologic evaluation, such as epidural/subdural empyema, intracranial abscess.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Surgical site infections - superficial infections requiring hospitalization.
Incidence of superficial surgical site infections, based on clinical and/or radiologic evaluation such as skin erythema, swelling, tenderness, purulent/serous discharge skin necrosis that require hospitalization. Evaluation of timing of infections diagnoses after primary surgical intervention.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Surgical site infections - superficial infections not requiring hospitalization.
Incidence of superficial surgical site infections, based on clinical and/or radiologic evaluation such as skin erythema, swelling, tenderness, purulent/serous discharge skin necrosis that do not require hospitalization. Evaluation of timing of infections diagnoses after primary surgical intervention.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Economic Evaluation - cost of materials used for interrupted skin closure.
Cost of materials used in patients whose skin was closed using interrupted non-absorbable sutures.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Economic Evaluation - cost of materials used for continuous skin closure.
Costs of skin closure materials used in patients whose skin was closed using using the continuous absorbable suture.
Time frame: From enrollment to the final wound assessment timepoint - 90 days postoperatively.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2028, 24 months after the start.
Of 310 non-industry interventional studies with no phase under Brain Neoplasms, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 36 and three quarters within 126. This study's planned 24 months is below that.
Counting every sponsor, half of 321 studies reached it within 64 months; a quarter within 35 and three quarters within 125.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Warsaw →